Targeting TRPV1 for pain relief: limits, losers and laurels
- PMID: 22780443
- DOI: 10.1517/13543784.2012.704021
Targeting TRPV1 for pain relief: limits, losers and laurels
Abstract
Introduction: With 336 reviews, the capsaicin receptor TRPV1 arguably represent today's most extensively reviewed analgesic target. TRPV1 is strategically located at the peripheral terminals of primary sensory neurons where pain is generated. TRPV1 as a target for analgesic drugs has been validated in preclinical studies.
Areas covered: The therapeutic potential of targeting TRPV1 by agonists and antagonists for pain relief is discussed based on our experience and a critical review of the literature. Strategies to overcome adverse effects are explored.
Expert opinion: Since its discovery in 1997, TRPV1 has run the gamut from excitement to disappointment to cautious optimism. Topical capsaicin has been disappointing for pain relief. By contrast, intrathecal resiniferatoxin is currently undergoing clinical trials in patients with intractable cancer pain. Some of the small-molecule TRPV1 antagonists have successfully passed Phase I safety and tolerability studies in healthy volunteers into Phase II studies to access efficacy in patients. Others showed worrisome unforeseen adverse effects, most important, hyperthermia and impaired noxious heat sensation. We conclude that TRPV1 blockade and desensitization are two promising, complimentary approaches for pain relief. Despite the roadblocks, TRPV1 remains a powerful tool in pain research and a promising therapeutic target.
Similar articles
-
Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.Brain Res Rev. 2009 Apr;60(1):267-77. doi: 10.1016/j.brainresrev.2008.12.006. Epub 2008 Dec 25. Brain Res Rev. 2009. PMID: 19150372 Review.
-
Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?Clin J Pain. 2008 Feb;24(2):142-54. doi: 10.1097/AJP.0b013e318158ed9e. Clin J Pain. 2008. PMID: 18209521 Review.
-
Transient receptor potential vanilloid 1 as a therapeutic target in analgesia.Expert Opin Ther Targets. 2013 Jun;17(6):641-57. doi: 10.1517/14728222.2013.772580. Epub 2013 Feb 20. Expert Opin Ther Targets. 2013. PMID: 23421411 Review.
-
Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold thresholds in the rat.Eur J Pain. 2010 May;14(5):480-6. doi: 10.1016/j.ejpain.2009.08.005. Epub 2009 Oct 1. Eur J Pain. 2010. PMID: 19800272
-
Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.Drug Discov Today. 2009 Jan;14(1-2):56-67. doi: 10.1016/j.drudis.2008.11.005. Epub 2008 Dec 26. Drug Discov Today. 2009. PMID: 19063991 Review.
Cited by
-
In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity.Pharmaceutics. 2022 Nov 22;14(12):2563. doi: 10.3390/pharmaceutics14122563. Pharmaceutics. 2022. PMID: 36559057 Free PMC article.
-
Extrasynaptic α5GABAA receptors on proprioceptive afferents produce a tonic depolarization that modulates sodium channel function in the rat spinal cord.J Neurophysiol. 2018 Dec 1;120(6):2953-2974. doi: 10.1152/jn.00499.2018. Epub 2018 Sep 26. J Neurophysiol. 2018. PMID: 30256739 Free PMC article.
-
TRPV1: Role in Skin and Skin Diseases and Potential Target for Improving Wound Healing.Int J Mol Sci. 2021 Jun 7;22(11):6135. doi: 10.3390/ijms22116135. Int J Mol Sci. 2021. PMID: 34200205 Free PMC article. Review.
-
The preventive effect of resiniferatoxin on the development of cold hypersensitivity induced by spinal nerve ligation: involvement of TRPM8.BMC Neurosci. 2016 Jun 21;17(1):38. doi: 10.1186/s12868-016-0273-8. BMC Neurosci. 2016. PMID: 27329106 Free PMC article.
-
Resiniferatoxin: The Evolution of the "Molecular Scalpel" for Chronic Pain Relief.Pharmaceuticals (Basel). 2016 Aug 11;9(3):47. doi: 10.3390/ph9030047. Pharmaceuticals (Basel). 2016. PMID: 27529257 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
